SynthesisBMC cancer2021

Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials.

Wu Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.